Comments
India drugs inquiry could prompt new U.S. scrutiny
11.05.2012. | WASHINGTON (Reuters) - Global drugmakers could face new U.S. scrutiny after a report from lawmakers in India alleged abuses in that country's drug approval process, lawyers familiar with such investigations said....
